Swiss drugmaker Roche(ROG.S)predicted on Wednesday that demand for its drugs would accelerate for the remainder of 2021, after first-quarter sales of COVID-19 tests offset a pandemic-influenced slump in its main pharmaceuticals business.
Swiss drugmaker Novartis raised its full-year guidance on wider use of psoriasis and arthritis drug Cosentyx on Tuesday and said it had tapped the former…
The U.S. health regulator approved on Monday ImmunityBio’s combination therapy to treat a type of bladder cancer, marking an end to the company’s efforts to…
Swiss drugmaker Novartis on Tuesday raised its full-year guidance after reporting better-than-expected first-quarter results.
Abeona Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had declined to approve its treatment for a rare skin blistering condition, sending…
The U.S. health regulator approved on Monday ImmunityBio’s combination therapy to treat a type of bladder cancer, marking an end to the company’s efforts to…
Bayer confirmed its full-year forecast for earnings and cash flow on Monday despite slow business at its crop science and consumer health divisions.
Abeona Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had declined to approve its treatment for a rare skin blistering condition, sending…
Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals to produce injectable medicines.
The U.S. Food and Drug Administration approved ImmunityBio’s combination therapy to treat a type of bladder cancer, the regulator said on Monday, allowing the company’s…
Abeona Therapeutics said on Monday the U.S. health regulator had declined to approve its treatment for a rare skin blistering condition.
